KMID : 0620920200520010007
|
|
Experimental & Molecular Medicine 2020 Volume.52 No. 1 p.7 ~ p.7
|
|
Role of interleukin-23 in the development of nonallergic eosinophilic inflammation in a murine model of asthma
|
|
Lee Hyun-Seung
Park Da-Eun Lee Ji-Won Sohn Kyung-Hee Cho Sang-Heon Park Heung-Woo
|
|
Abstract
|
|
|
Nonallergic eosinophilic asthma (NAEA) is a clinically distinct subtype of asthma. Thus far, the pathophysiologic mechanisms underlying NAEA have not been fully elucidated. This study aimed to determine the role of IL-23 in the pathogenesis of NAEA. We developed a murine model of NAEA using recombinant IL-23 (rIL-23) plus a nonspecific airway irritant [polyinosinic-polycytidylic acid (polyI:C) or diesel exhaust particles (DEPs)] and investigated whether IL-23 plays an important role in the development of NAEA. Intranasal administration of rIL-23 (0.1?¥ìg/mouse) plus polyI:C (0.01?¥ìg/mouse) or DEPs (10?¥ìg/mouse) without allergen resulted in methacholine bronchial hyperresponsiveness and eosinophilic airway inflammation in mice, which are characteristic features of NAEA. rIL-23 plus a low dose nonspecific airway irritants induced the release of innate cytokines from airway epithelium, including IL-33, thymic stromal lymphopoietin and IL-1¥â; these factors activated types 2 and 3 innate lymphoid cells (ILC2s and ILC3s). ILC2s and ILC3s, but not CD4+ T cells (i.e., adaptive immune cells), were important in the development of NAEA. In addition, we observed that IL-23 receptor expressions increased in airway epithelial cells, which suggests the existence of a positive autocrine loop in our murine model of NAEA. To our knowledge, this is the first report in which administration of rIL-23 plus a nonspecific airway irritant (polyI:C or DEPs) without allergen resulted in features of NAEA in mice similar to those found in humans. IL-23 may constitute a therapeutic target for NAEA in humans.
|
|
KEYWORD
|
|
Asthma, Innate immunity
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|